BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27692539)

  • 1. Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.
    Liu Y; Chen W; Wu C; Minze LJ; Kubiak JZ; Li XC; Kloc M; Ghobrial RM
    J Heart Lung Transplant; 2017 Mar; 36(3):340-354. PubMed ID: 27692539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.
    Chen W; Chen S; Chen W; Li XC; Ghobrial RM; Kloc M
    Transpl Immunol; 2018 Oct; 50():15-25. PubMed ID: 29885441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siponimod (Mayzent) Downregulates RhoA and Cell Surface Expression of the S1P1 and CX3CR1 Receptors in Mouse RAW 264.7 Macrophages.
    Uosef A; Vaughn N; Chu X; Elshawwaf M; Abdelshafy AAA; Elsaid KMK; Ghobrial RM; Kloc M
    Arch Immunol Ther Exp (Warsz); 2020 Jun; 68(3):19. PubMed ID: 32488676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Fractalkine-CX3CR1 Axis in Acute Rejection of Mouse Heart Allografts Subjected to Ischemia Reperfusion Injury.
    Kanzawa T; Tokita D; Saiga K; Yamakawa T; Ishigooka H; Fukuda H; Katsumata H; Miyairi S; Ishii R; Hirai T; Imai T; Okumi M; Tanabe K
    Transpl Int; 2022; 35():10157. PubMed ID: 35185378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent role of donor dendritic cells in rejection versus tolerance of allografts.
    Ueno T; Tanaka K; Jurewicz M; Murayama T; Guleria I; Fiorina P; Paez JC; Augello A; Vergani A; Wong M; Smith RN; Abdi R
    J Am Soc Nephrol; 2009 Mar; 20(3):535-44. PubMed ID: 19129312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
    Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
    Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROCK inhibition impedes macrophage polarity and functions.
    Liu Y; Tejpal N; You J; Li XC; Ghobrial RM; Kloc M
    Cell Immunol; 2016 Feb; 300():54-62. PubMed ID: 26711331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide increases monocyte binding to mesangial cells through fractalkine and its receptor.
    Park J; Song KH; Ha H
    Transplant Proc; 2012 May; 44(4):1029-31. PubMed ID: 22564617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.
    Zhang L; You J; Sidhu J; Tejpal N; Ganachari M; Skelton TS; Kloc M; Li XC; Ghobrial RM
    Transplantation; 2013 Nov; 96(9):782-90. PubMed ID: 23985719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.
    Gu G; Huang Y; Wu C; Guo Z; Ma Y; Xia Q; Awasthi A; He X
    Transplantation; 2017 Jan; 101(1):83-91. PubMed ID: 27575691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
    Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
    J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
    Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
    J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin enhances cardiac transplant rejection.
    Shen H; Heuzey E; Mori DN; Wong CK; Colangelo CM; Chung LM; Bruce C; Slizovskiy IB; Booth CJ; Kreisel D; Goldstein DR
    Circ Res; 2015 May; 116(10):1670-9. PubMed ID: 25801896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection.
    Sun Y; Feng J; Shi J; Lu X; Xie A; Chen Y; Dong N
    Transplantation; 2014 Jun; 97(12):1233-9. PubMed ID: 24825519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
    Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
    Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.